Daniel Camardo
Director/Board Member at CommunityHealth NFP
Net worth: 1 141 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Aaron Cox | M | 41 | 8 years | |
Kasey Rosado | F | 50 | 2 years | |
Ellen Gurley | F | - | 1 years | |
Michael DesJardin | M | 66 | 8 years | |
Irina P. Konstantinovsky | F | 54 | 7 years | |
Andy Pasternak | M | 53 | 5 years | |
Karin Rosen | M | 57 | 4 years | |
Jane Gonnerman | F | - | 3 years | |
Keli Walbert | F | - | 6 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Lehmann | M | 58 | 21 years | |
Ismail Kola | M | 67 | 13 years | |
Barry Moze | M | 70 | 8 years | |
John Harrington | M | 56 | 27 years | |
Ivor MacLeod | M | 63 | 2 years | |
Katherine Kalin | F | 61 | 2 years | |
Brian Beeler | M | 51 | 9 years | |
Maia Hansen | F | 55 | 3 years | |
Neema Mayhugh | M | 48 | 1 years | |
Baiju R. Shah | M | 52 | 2 years | |
Joseph Nolan | M | 61 | 1 years | |
Robert Metz | M | - | 10 years | |
Elizabeth Cermak | F | 66 |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | - |
James Shannon | M | 67 | 6 years | |
Mary Martin | M | - | 1 years | |
Pascale Witz | F | 57 | 6 years | |
Virinder Nohria | M | 70 | 3 years | |
Jeff Randall | M | 80 | 15 years | |
Susan Mahony | M | 59 | 4 years | |
Ronald E. Pauli | M | 63 | 8 years | |
Shao Lee Lin | M | 57 | 2 years | |
Ron Oyston | M | 54 | 3 years | |
petra Molan | F | - | 1 years | |
Rob Ortmann | M | - | 1 years | |
Javier Szwarcberg | M | 54 | 1 years | |
James Glover | M | - | 2 years | |
Elizabeth Thompson | M | 49 | - | |
Jennifer T. Lee | F | - | - | |
Michael Conick Hanley | M | 51 | 2 years | |
Jörn Drappa | M | 60 | - | |
David Happel | M | 62 | 2 years | |
Tim Ayers | M | - | 3 years | |
John J. Kody | M | - | 2 years | |
David Kelly | M | 63 | 4 years | |
Eric B. Mosbrooker | M | 46 | 2 years | |
Mark Prygocki | M | 58 |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | 8 years |
Patrick Ashe | M | 59 | - | |
Keith S. Swenson | M | - | - | |
Kenneth Traub | M | 62 | 1 years | |
John B. Thomas | M | - | 2 years | |
Hardy Kagimoto | M | 47 | 4 years | |
Steven Pfeiffer | M | 48 | 1 years | |
Robert Carey | M | 65 | 5 years | |
Sherri Stewart | F | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Ireland | 36 | 67.92% |
United States | 17 | 32.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Daniel Camardo
- Personal Network